• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转录因子FoxO1在多囊卵巢综合征发病机制中的作用

Involvement of Transcription Factor FoxO1 in the Pathogenesis of Polycystic Ovary Syndrome.

作者信息

Xu Renfeng, Wang Zhengchao

机构信息

Provincial Key Laboratory for Developmental Biology and Neurosciences, Provincial University Key Laboratory of Sport and Health Science, Key Laboratory of Optoelectronic Science and Technology for Medicine of Ministry of Education, College of Life Sciences, Fujian Normal University, Fuzhou, China.

出版信息

Front Physiol. 2021 Mar 5;12:649295. doi: 10.3389/fphys.2021.649295. eCollection 2021.

DOI:10.3389/fphys.2021.649295
PMID:33746783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7973228/
Abstract

FoxO1 is a member of the forkhead transcription factor family subgroup O (FoxO), which is expressed in many cell types, and participates in various pathophysiological processes, including cell proliferation, apoptosis, autophagy, metabolism, inflammatory response, cytokine expression, immune differentiation, and oxidative stress resistance. Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in the women of childbearing age, which is regulated a variety of signaling pathways. Currently, the specific mechanism underlying the pathogenesis of PCOS is still unclear. As an important transcription factor, FoxO1 activity might be involved in the pathophysiology of PCOS. PCOS has been associated with insulin resistance and low-grade inflammatory response. Therefore, the studies regarding the role of FoxO1 in the incidence and associated complications of PCOS will help provide novel ideas for establishing the treatment strategy of PCOS.

摘要

叉头框蛋白O1(FoxO1)是叉头转录因子家族O亚组(FoxO)的成员之一,在多种细胞类型中表达,并参与各种病理生理过程,包括细胞增殖、凋亡、自噬、代谢、炎症反应、细胞因子表达、免疫分化和抗氧化应激。多囊卵巢综合征(PCOS)是育龄期女性最常见的内分泌紊乱疾病,受多种信号通路调控。目前,PCOS发病机制的具体原因仍不清楚。作为一种重要的转录因子,FoxO1的活性可能参与了PCOS的病理生理过程。PCOS与胰岛素抵抗和低度炎症反应有关。因此,关于FoxO1在PCOS发病及相关并发症中的作用的研究,将有助于为制定PCOS的治疗策略提供新思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b8/7973228/223528281ddb/fphys-12-649295-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b8/7973228/223528281ddb/fphys-12-649295-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b8/7973228/223528281ddb/fphys-12-649295-g001.jpg

相似文献

1
Involvement of Transcription Factor FoxO1 in the Pathogenesis of Polycystic Ovary Syndrome.转录因子FoxO1在多囊卵巢综合征发病机制中的作用
Front Physiol. 2021 Mar 5;12:649295. doi: 10.3389/fphys.2021.649295. eCollection 2021.
2
The role of Sirtuin 1 in the pathophysiology of polycystic ovary syndrome.Sirtuin 1 在多囊卵巢综合征病理生理学中的作用。
Eur J Med Res. 2022 Aug 27;27(1):158. doi: 10.1186/s40001-022-00746-4.
3
Long non-coding RNA lnc-CCNL1-3:1 promotes granulosa cell apoptosis and suppresses glucose uptake in women with polycystic ovary syndrome.长链非编码RNA lnc-CCNL1-3:1促进多囊卵巢综合征女性颗粒细胞凋亡并抑制葡萄糖摄取。
Mol Ther Nucleic Acids. 2020 Dec 15;23:614-628. doi: 10.1016/j.omtn.2020.12.008. eCollection 2021 Mar 5.
4
Role of the transcriptional factors FOXO1 and PPARG on gene expression of SLC2A4 in endometrial tissue from women with polycystic ovary syndrome.转录因子 FOXO1 和 PPARG 对多囊卵巢综合征患者子宫内膜组织 SLC2A4 基因表达的作用。
Reproduction. 2010 Jul;140(1):123-31. doi: 10.1530/REP-10-0056. Epub 2010 Apr 20.
5
Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.噻唑烷二酮类药物用于多囊卵巢综合征的治疗管理:对代谢和生殖异常的影响
Treat Endocrinol. 2006;5(3):171-87. doi: 10.2165/00024677-200605030-00005.
6
Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.六味地黄丸通过 PI3K/Akt 信号通路改善胰岛素敏感性,从而缓解多囊卵巢综合征。
J Ethnopharmacol. 2020 Mar 25;250:111965. doi: 10.1016/j.jep.2019.111965. Epub 2019 Jun 8.
7
Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.饮食中碳水化合物的来源和含量与多囊卵巢综合征妇女的炎症反应。
Nutr Res Rev. 2018 Dec;31(2):291-301. doi: 10.1017/S0954422418000136. Epub 2018 Jul 23.
8
Sex hormone-binding globulin and polycystic ovary syndrome.性激素结合球蛋白与多囊卵巢综合征。
Clin Chim Acta. 2019 Dec;499:142-148. doi: 10.1016/j.cca.2019.09.010. Epub 2019 Sep 13.
9
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.美国临床内分泌医师协会、美国内分泌学会以及雄激素过多与多囊卵巢综合征协会疾病状态临床综述:多囊卵巢综合征评估与治疗最佳实践指南 - 第2部分。
Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2.
10
Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome.高雄激素血症和胰岛素抵抗引起的胎儿丢失:模拟多囊卵巢综合征临床特征的孕鼠胎盘线粒体异常和活性氧产生增加的证据。
J Physiol. 2019 Aug;597(15):3927-3950. doi: 10.1113/JP277879. Epub 2019 Jul 3.

引用本文的文献

1
Decoding androgen excess in polycystic ovary syndrome: Roles of insulin resistance and other key intraovarian and systemic factors.解读多囊卵巢综合征中的雄激素过多:胰岛素抵抗及其他关键的卵巢内和全身因素的作用
World J Diabetes. 2025 Jul 15;16(7):108789. doi: 10.4239/wjd.v16.i7.108789.
2
Integrative single-cell transcriptomics of sheep ovarian development reveals dynamic transcriptional programs relevant to reproductive traits.绵羊卵巢发育的整合单细胞转录组学揭示了与繁殖性状相关的动态转录程序。
iScience. 2025 Apr 14;28(5):112422. doi: 10.1016/j.isci.2025.112422. eCollection 2025 May 16.
3
Downregulation of FOXO1 in PCOS Granulosa Cells: A Direct Target of microRNA-183.

本文引用的文献

1
Obesity and polycystic ovary syndrome.肥胖与多囊卵巢综合征。
Clin Endocrinol (Oxf). 2021 Oct;95(4):531-541. doi: 10.1111/cen.14421. Epub 2021 Jan 31.
2
Cangfudaotan Decoction Alleviates Insulin Resistance and Improves Follicular Development in Rats with Polycystic Ovary Syndrome via IGF-1-PI3K/Akt-Bax/Bcl-2 Pathway.苍附导痰汤通过 IGF-1-PI3K/Akt-Bax/Bcl-2 通路改善多囊卵巢综合征大鼠胰岛素抵抗及卵泡发育。
Mediators Inflamm. 2020 Nov 24;2020:8865647. doi: 10.1155/2020/8865647. eCollection 2020.
3
Endocrine disruptors, obesity, and cytokines - how relevant are they to PCOS?
多囊卵巢综合征颗粒细胞中FOXO1的下调:微小RNA-183的直接靶点
Reprod Sci. 2025 May 30. doi: 10.1007/s43032-025-01886-8.
4
miR-138-5p inhibits healing of femoral fracture osteogenesis in rats by modulating osteoblast differentiation via SIRT1/FOXO1 axis.微小RNA-138-5p通过SIRT1/FOXO1轴调节成骨细胞分化来抑制大鼠股骨骨折的愈合。
J Orthop Surg Res. 2025 Mar 14;20(1):280. doi: 10.1186/s13018-025-05667-6.
5
Polycystic Ovary Syndrome and Ferroptosis: Following Ariadne's Thread.多囊卵巢综合征与铁死亡:追寻阿里阿德涅之线
Biomedicines. 2024 Oct 8;12(10):2280. doi: 10.3390/biomedicines12102280.
6
Shared diagnostic genes and potential mechanisms between polycystic ovary syndrome and recurrent miscarriage revealed by integrated transcriptomics analysis and machine learning.整合转录组学分析和机器学习揭示多囊卵巢综合征和复发性流产之间的共享诊断基因和潜在机制。
Front Endocrinol (Lausanne). 2024 Sep 27;15:1335106. doi: 10.3389/fendo.2024.1335106. eCollection 2024.
7
Exploring the Potential of Natural Products as FoxO1 Inhibitors: an Approach.探索天然产物作为FoxO1抑制剂的潜力:一种方法。
Biomol Ther (Seoul). 2024 May 1;32(3):390-398. doi: 10.4062/biomolther.2023.156. Epub 2024 Apr 9.
8
Diagnostic predictability of serum miR-4793-3p and miR-1180-3p expression in community-acquired pneumonia.血清 miR-4793-3p 和 miR-1180-3p 表达对社区获得性肺炎的诊断预测性。
Biomark Med. 2024;18(6):231-241. doi: 10.2217/bmm-2023-0463. Epub 2024 Mar 8.
9
Inhibition of FoxO1 alleviates polycystic ovarian syndrome by reducing inflammation and the immune response.抑制FoxO1可通过减轻炎症和免疫反应来缓解多囊卵巢综合征。
Funct Integr Genomics. 2024 Jan 8;24(1):6. doi: 10.1007/s10142-024-01284-4.
10
The physiological functions and therapeutic potential of exosomes during the development and treatment of polycystic ovary syndrome.多囊卵巢综合征发生发展及治疗过程中外泌体的生理功能与治疗潜力
Front Physiol. 2023 Nov 6;14:1279469. doi: 10.3389/fphys.2023.1279469. eCollection 2023.
内分泌干扰物、肥胖和细胞因子——它们与 PCOS 有何关联?
Physiol Res. 2020 Sep 30;69(Suppl 2):S279-S293. doi: 10.33549/physiolres.934521.
4
Cryptotanshinone alleviates polycystic ovary syndrome in rats by regulating the HMGB1/TLR4/NF‑κB signaling pathway.隐丹参酮通过调节 HMGB1/TLR4/NF-κB 信号通路缓解多囊卵巢综合征大鼠的症状。
Mol Med Rep. 2020 Nov;22(5):3851-3861. doi: 10.3892/mmr.2020.11469. Epub 2020 Aug 28.
5
Upregulation of microRNA-204 improves insulin resistance of polycystic ovarian syndrome via inhibition of HMGB1 and the inactivation of the TLR4/NF-κB pathway.miR-204 的上调通过抑制 HMGB1 和 TLR4/NF-κB 通路的失活来改善多囊卵巢综合征的胰岛素抵抗。
Cell Cycle. 2020 Mar;19(6):697-710. doi: 10.1080/15384101.2020.1724601. Epub 2020 Feb 23.
6
MiRNAs Regulating Insulin Sensitivity Are Dysregulated in Polycystic Ovary Syndrome (PCOS) Ovaries and Are Associated With Markers of Inflammation and Insulin Sensitivity.调节胰岛素敏感性的微小RNA在多囊卵巢综合征(PCOS)卵巢中表达失调,并与炎症和胰岛素敏感性标志物相关。
Front Endocrinol (Lausanne). 2019 Dec 13;10:879. doi: 10.3389/fendo.2019.00879. eCollection 2019.
7
and gene expression are reduced and high mobility group box 1 (HMGB1) is increased in the ovaries and serum of women with polycystic ovarian syndrome.并且多囊卵巢综合征患者的卵巢和血清中基因表达减少,高迁移率族蛋白 B1(HMGB1)增加。
Gynecol Endocrinol. 2019 Oct;35(10):842-846. doi: 10.1080/09513590.2019.1599349. Epub 2019 Apr 9.
8
TCF19 enhances cell proliferation in hepatocellular carcinoma by activating the ATK/FOXO1 signaling pathway.TCF19 通过激活 ATK/FOXO1 信号通路增强肝癌细胞增殖。
Neoplasma. 2019 Jan 15;66(1):46-53. doi: 10.4149/neo_2018_171227N845. Epub 2018 Aug 9.
9
The regulation of FOXO1 and its role in disease progression.FOXO1的调控及其在疾病进展中的作用。
Life Sci. 2018 Jan 15;193:124-131. doi: 10.1016/j.lfs.2017.11.030. Epub 2017 Nov 20.
10
Roles of Hypothalamic-Pituitary-Adrenal Axis and Hypothalamus-Pituitary-Ovary Axis in the Abnormal Endocrine Functions in Patients with Polycystic Ovary Syndrome.下丘脑-垂体-肾上腺轴及下丘脑-垂体-卵巢轴在多囊卵巢综合征患者内分泌功能异常中的作用
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017 Oct 30;39(5):699-704. doi: 10.3881/j.issn.1000-503X.2017.05.017.